<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 12 (filtered)">
<title>House Bill</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
h1
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Courier New";}
h3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Courier New";}
p.XNotesHeading, li.XNotesHeading, div.XNotesHeading
	{mso-style-name:XNotesHeading;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Courier New";
	font-weight:bold;}
p.XNotes, li.XNotes, div.XNotes
	{mso-style-name:XNotes;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.Constitution, li.Constitution, div.Constitution
	{mso-style-name:Constitution;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.1Paragraph, li.1Paragraph, div.1Paragraph
	{mso-style-name:"\(1\)Paragraph";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-indent:-1.0in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.aSubsection, li.aSubsection, div.aSubsection
	{mso-style-name:"\(a\)Subsection";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.ASubparagraph, li.ASubparagraph, div.ASubparagraph
	{mso-style-name:"\(A\)Subparagraph";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.5in;
	margin-bottom:.0001pt;
	text-indent:-1.5in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.iClause, li.iClause, div.iClause
	{mso-style-name:"\(i\)Clause";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-indent:-2.0in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.ASubparagraphContd, li.ASubparagraphContd, div.ASubparagraphContd
	{mso-style-name:"\(A\)SubparagraphContd";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.5in;
	margin-bottom:.0001pt;
	text-indent:-1.5in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.1ParagraphContd, li.1ParagraphContd, div.1ParagraphContd
	{mso-style-name:"\(1\)ParagraphContd";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-indent:-1.0in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.RegularParagraphs, li.RegularParagraphs, div.RegularParagraphs
	{mso-style-name:"\#Regular Paragraphs";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=RegularParagraphs>     <b>§329-75  Sales of products, mixtures, or
preparations containing pseudoephedrine; reporting requirement for wholesalers.</b> 
(a)  Notwithstanding any other law to the contrary, a pharmacy or retailer may
sell or distribute to a person without a prescription not more than 3.6 grams
per day, without regard to the number of transactions, of any product, mixture,
or preparation containing any detectable quantity of pseudoephedrine, its
salts, optical isomers, or salts of optical isomers as the only active ingredient
or in combination with other active ingredients; provided that the pharmacy or
retailer shall comply with the following conditions:</p>

<p class=1Paragraph>     (1)  The product, mixture, or preparation shall be
sold or distributed from an area not accessible by customers or the general
public, such as behind the counter or in a locked display case and where the
seller delivers the product directly into the custody of the purchaser;</p>

<p class=1Paragraph>     (2)  Any person purchasing or otherwise acquiring any
product, mixture, or preparation shall produce proper identification containing
the photograph, date of birth, printed name, signature, and address of the
individual obtaining the substance;</p>

<p class=1Paragraph>     (3)  The pharmacy or retailer shall record, in an
electronic log on software provided by the narcotics enforcement division of
the department and approved by the administrator:</p>

<p class=ASubparagraph>         (A)  The date of any transaction under
paragraph (2);</p>

<p class=ASubparagraph>         (B)  The name, address, and date of birth of
the person;</p>

<p class=ASubparagraph>         (C)  The type of identification provided by the
individual obtaining the substance;</p>

<p class=ASubparagraph>         (D)  The agency issuing the identification
used; and</p>

<p class=ASubparagraph>         (E)  The name of the compound, mixture, or
preparation, and the amount; and</p>

<p class=1Paragraph>     (4)  The pharmacy or retailer shall:</p>

<p class=ASubparagraph>         (A)  Record the information required under
paragraph (3) on an electronic worksheet on software provided by the narcotics
enforcement division of the department; and</p>

<p class=ASubparagraph>         (B)  Electronically mail the worksheet record
to the narcotics enforcement division once a month.</p>

<p class=1Paragraph>          The information shall be retained by the pharmacy
or retailer for a period of two years.  The electronic log shall be capable of
being checked for compliance against all state and federal laws, including
interfacing with other states to ensure comprehensive compliance, and shall be
subject to random and warrantless inspection by county or state law enforcement
officers.</p>

<p class=RegularParagraphs>     (b)  No person shall knowingly purchase,
possess, receive, or otherwise acquire more than nine grams of any product,
mixture, or preparation containing any detectable quantity of pseudoephedrine
or its salts, isomers, or salts of optical isomers within a thirty-day period,
except that this limit shall not apply to any quantity of such product,
mixture, or preparation dispensed pursuant to a valid prescription.</p>

<p class=RegularParagraphs>     (c)  Any person who violates subsection (b) is guilty
of a class C felony.</p>

<p class=RegularParagraphs>     (d)  The department, by rule, may exempt other
products from this section, if the administrator finds that the products are
not used in the illegal manufacture of methamphetamine or other controlled
substances.  A manufacturer of a drug product may apply for removal of the
product from this section if the product is determined by the administrator to
have been formulated in such a way as to effectively prevent the conversion of
the active ingredient into methamphetamine.</p>

<p class=RegularParagraphs>     (e)  Notwithstanding any other provision of
this chapter to the contrary, every wholesaler shall report to the
administrator all sales made to any retailer, of any product, mixture, or
preparation containing any detectable quantity of pseudoephedrine, its salts,
optical isomers, or salts of optical isomers, as the only active ingredient or
in combination with other active ingredients.  The department shall provide a
common reporting form that contains at least the following information about
the product, mixture, or preparation:</p>

<p class=1Paragraph>     (1)  Generic or other name;</p>

<p class=1Paragraph>     (2)  Quantity sold;</p>

<p class=1Paragraph>     (3)  Date of sale;</p>

<p class=1Paragraph>     (4)  Name and address of the wholesaler; and</p>

<p class=1Paragraph>     (5)  Name and address of the retailer.</p>

<p class=RegularParagraphs>     (f)  Intentional or knowing failure of a
retailer or pharmacy to transmit any information as required by this section
shall be a misdemeanor and shall result in the immediate suspension of that
retailer's ability to sell any product, mixture, or preparation containing any
detectable quantity of pseudoephedrine, its salts, optical isomers, or salts of
optical isomers as the only active ingredient or in combination with other
active ingredients until authorized by the administrator. [L 2005, c 193, pt of
§1; am L 2006, c 171, §3; am L 2008, c 119, §7 and c 184, §1]</p>

<p class=RegularParagraphs>&nbsp;</p>

<p class=RegularParagraphs>&nbsp;</p>

</div>

</body>

</html>
<center><table border="0" width="90%"><tr>
<td align="left"><a href="/hrscurrent/Vol06_Ch0321-0344/HRS0329/HRS_0329-0074.htm">Previous</a></td>
<td align="center"><a href=/hrscurrent/Vol06_Ch0321-0344>Vol06_Ch0321-0344</a></td>
<td align="right"><a href="/hrscurrent/Vol06_Ch0321-0344/HRS0329/HRS_0329-0081.htm">Next</a></td>
</tr></table></center>
